FEDERAL COURT OF AUSTRALIA
Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd (No 2)
[2016] FCAFC 111
Appeal from: Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd (No 4) (2015) 113 IPR 191; [2015] FCA 634 File number: NSD 837 of 2015 Judges: BESANKO, NICHOLAS AND BEACH JJ Date of judgment: 24 August 2016 Catchwords: PATENTS – appeal against decision of primary judge that appellants’ claims were invalid for lack of novelty and lack of inventive step – where primary judge held respondent would have infringed appellants’ claims had they been valid – where patent concerns carbostyril compound called aripiprazole and its use in treatment of schizophrenia – where primary judge held features of claims accretions to knowledge or arbitrary not sufficient to give rise to novelty – whether primary judge’s conclusions about novelty and inventive step based on a flawed construction of the claims – whether primary judge erred in not construing a feature as an essential feature or integer of a claim – whether primary judge erred in finding a feature arbitrary Legislation: Patents Act 1990 (Cth) ss 7, 13, 117 Cases cited: Actavis UK Ltd v Janssen Pharmaceuticals NV [2008] FSR 35
Actavis UK Ltd v Merck & Co Inc [2009] 1 WLR 1186
Apotex Pty Ltd v Sanofi-Aventis Australia Pty Limited [2013] HCA 50; (2013) 304 ALR 1
Bristol-Myers Squibb v Baker Norton Pharmaceuticals Inc [1999] RPC 253
British Celanese, Ltd v Courtaulds, Ltd (1935) 52 RPC 171
EISAI/Second Medical Indication (G05/83) [1979-85] EPOR B241
Electric and Musical Industries, Ld and Boonton Research Corporation, Ltd v Lissen, Ltd and another (1939) 56 RPC 23
Fresenius Medical Care Australia Pty Ltd v Gambro Pty Ltd and Another [2005] FCAFC 220; (2005) 67 IPR 230
General Tire & Rubber Company v Firestone Tyre and Rubber Company Limited and Others [1972] RPC 457
Kinabalu Investments Pty Ltd v Barron and Rawson Pty Ltd [2008] FCAFC 178
Lockwood Security Products Pty Ltd v Doric Products Pty Ltd [No 2] [2007] HCA 21; (2007) 235 CLR 173
Martin v Scribal Proprietary Limited (1954) 92 CLR 17
MOBIL/Friction Reducing Additive (G02/88) [1990] EPOR 73
Osram Lamp Works Ld v Pope’s Electric Lamp Company Ld (1917) 34 RPC 369
Raychem Corporation’s Patents [1998] RPC 31
Root Quality Pty Ltd and Another v Root Control Technologies Pty Ltd and Others [2000] FCA 980; (2000) 49 IPR 225
Sartas No 1 v Koukourou & Partners Pty Ltd and Another (1994) 30 IPR 479
Blanco White TA, Patents for inventions and the protection of industrial designs (5th ed, Stevens, 1983)
Dates of hearing: 12 and 13 November 2015 Registry: New South Wales Division: General Division National Practice Area: Intellectual Property Sub-area: Patents and associated Statutes Category: Catchwords Number of paragraphs: 179 Counsel for the Appellants: Mr AJL Bannon SC with Ms CL Cochrane and Mr BA Mee Solicitor for the Appellants: Allens Counsel for the Respondent: Mr AJ Ryan SC with Mr ADB Fox Solicitor for the…
Keep reading for free
Create a free CaseChat account to read Otsuka Pharmaceutical Co Ltd v Generic Health Pty Ltd (No 2) and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2016] FCAFC 111
- Decision Date
CaseChat Overview and Summary
The court examined the construction of the patent claims, specifically whether they should be characterised as product claims or method or process claims. The primary judge held that "method or process" were apt to describe the content and subject matter of the Swiss type claim, a conclusion that the court found to be consistent with relevant authorities. The court also considered the state of knowledge at the priority date and the evidence presented by both parties, including expert and lay evidence. The appellants argued that the primary judge's conclusions about novelty and inventive step were flawed, while the respondent maintained that the claims were not novel and lacked an inventive step. The court found that the primary judge had correctly considered the state of knowledge and evidence when reaching his conclusions.
The court ultimately dismissed the appeal, holding that the primary judge's conclusions about the validity of the patent claims were correct. The court also found that the primary judge had not erred in his construction of the claims or in his assessment of the features. As a result, the patent claims were invalid for lack of novelty and lack of inventive step. The court ordered that the appeal be dismissed and that the appellants pay the respondent's costs of the appeal.
Orders
Orders of the court
1. The appeal be dismissed.
2. The appellants pay the respondent’s costs of the appeal.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Evidence
Evidence Before The Court
Decision